Page last updated: 2024-08-24
irinotecan and alloin
irinotecan has been researched along with alloin in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chang, YC; Chen, MC; Ho, TJ; Hsieh, DJ; Huang, CY; Jassi, C; Kuo, CH; Kuo, WW; Li, CC; Wang, TF | 1 |
Other Studies
1 other study(ies) available for irinotecan and alloin
| Article | Year |
|---|---|
Aloin and CPT-11 combination activates miRNA-133b and downregulates IGF1R- PI3K/AKT/mTOR and MEK/ERK pathways to inhibit colorectal cancer progression.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Irinotecan; MAP Kinase Signaling System; Mice; MicroRNAs; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2023 |